Bifido Co Ltd
KOSDAQ:238200
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Bifido Co Ltd
Net Income (Common)
Bifido Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bifido Co Ltd
KOSDAQ:238200
|
Net Income (Common)
-₩192.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Net Income (Common)
₩235.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
46%
|
CAGR 10-Years
-9%
|
|
|
Amorepacific Group
KRX:002790
|
Net Income (Common)
₩112.5B
|
CAGR 3-Years
22%
|
CAGR 5-Years
79%
|
CAGR 10-Years
-8%
|
|
|
Cosmax Inc
KRX:192820
|
Net Income (Common)
₩123.1B
|
CAGR 3-Years
81%
|
CAGR 5-Years
42%
|
CAGR 10-Years
19%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Net Income (Common)
-₩100.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Net Income (Common)
₩125.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
11%
|
|
Bifido Co Ltd
Glance View
Bifido Co. Ltd. provides probiotics research and product development services. The company is headquartered in Hongcheon, Gangwon-Do. The company went IPO on 2018-12-26. The firm manufactures and sells probiotics health functional foods for infants, kids, adults, and women. These products are sold under the brand name of ZIGUNUK BIFIDUS. The firm also provides supplementary feeds for pets, as well as cosmetics including creams and serum. In addition, the Company produces raw materials for probiotics and fermented ginseng.
See Also
What is Bifido Co Ltd's Net Income (Common)?
Net Income (Common)
-192.7m
KRW
Based on the financial report for Dec 31, 2025, Bifido Co Ltd's Net Income (Common) amounts to -192.7m KRW.
What is Bifido Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
19%
Over the last year, the Net Income (Common) growth was 96%.
